I will say that we work hard to make sure that our relationships with our suppliers are maintained and are strong. That allows us to continue to press them for additional deliveries. We have ongoing discussions with them to advance the acceleration of doses.
There is a relationship issue that has to be understood in the context of these negotiations. We come to the table. We tell Pfizer, for example, exactly what it is that we would like to see. I will say that Pfizer has been a very strong partner for Canada in terms of continuing to accelerate deliveries in a time when Canada and all Canadians would like to see more and more vaccines.